The Exchange with Stuart Widdowson of Odyssean Capital
Why It Matters
A resurgence of overseas capital into UK small caps, combined with defence‑driven earnings upgrades, could spark a multi‑year rally and offer investors high‑conviction, undervalued opportunities.
Key Takeaways
- •US value funds show renewed interest in UK small‑cap equities.
- •Spire Healthcare undervalued despite NHS revenue dip and pending sale.
- •James Fisher’s debt reduction fuels operational turnaround and defense growth.
- •Defense‑focused marine assets like tactical rebreathers present high upside.
- •G&H’s niche optics gain from industrial recovery and defense demand.
Summary
The interview with Stuart Widdowson of Odyssean Capital centered on the outlook for UK small‑cap stocks amid heightened geopolitical risk, a softening private‑credit market, and technology sector uncertainty. Widdowson highlighted a surprising shift: while domestic UK investors continue to pull back, a wave of US‑based value managers has begun buying into the segment, signalling renewed confidence in medium‑term value creation.
Key insights included a bullish view that UK small caps could deliver a 20% rally within the next 12‑18 months, driven by fresh overseas capital. Specific holdings were dissected: Spire Healthcare, the nation’s largest private hospital operator, appears undervalued at a market price well below its £180 million asset base, even after accounting for a modest 25% NHS revenue exposure. James Fisher, a marine services firm, has slashed net debt to 1.3 × EBITDA, lifted operating margins from 4‑5% to 7.5% with a 10% target, and is capitalising on defense contracts such as tactical rebreathers, submarine‑rescue systems, and high‑speed special‑forces craft. G&H, a specialist optics producer, is benefitting from a multi‑year industrial recovery and a niche defence demand for laser‑coated periscopes and other precision components.
Widdowson’s remarks underscored the strategic importance of defence‑related growth platforms: “The market now sees James Fisher as investable again because the operational transformation is delivering real cash flow and a clear path to higher margins.” He also noted that Spire’s property revaluation has not been updated, leaving a hidden store of value. In the optics space, G&H’s unique coating technology is among a handful of global suppliers, positioning it for sustained demand from both civilian and military customers.
The implications are clear for investors: a potential reversal of capital outflows, especially from US funds, could re‑price UK small caps, rewarding those with solid balance sheets and defence exposure. Companies that have executed debt reductions, operational turnarounds, and asset optimisation are poised to capture upside as geopolitical tensions drive defence spending, while undervalued assets like Spire present opportunistic entry points.
Comments
Want to join the conversation?
Loading comments...